What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Assess which Dividend Aristocrats ETF offers the lowest expenses while maintaining solid diversification and dividend potential for your portfolio.
27,511 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Tuesday brought a modest pullback for Salesforce as tech stocks wobbled. This article explains the drivers behind the...
Meta and Microsoft posted strong results, yet insider selling patterns diverged sharply. Meta's executives have been ...
A dementia diagnosis reshapes retirement plans as custodial care bills far exceed medical costs and Medicare coverage...
In 2026, the $2,000 social security check is the main retirement income for many low- and middle-income Americans. Th...
Retirees should stay alert as the social security cola update unfolds. This guide explains how COLA works, which numb...
Ether.fi undertakes a major shift, moving its crypto card rails to OP Mainnet from Scroll, migrating tens of thousand...
Sensational headlines can tug at your wallet. This guide shows you how to separate rumor from reality, vet financial ...
A Sunrun director recently disposed of a large block of shares. This article breaks down insider sales, what they imp...
Tempus AI is set to report quarterly earnings after the close, with investors watching for growth signals and profita...
A widely followed crypto trader called Cardano ADA one of his worst investments, igniting a cross-community debate ab...
Bitcoin neared $63,000 as geopolitical tensions fueled risk-off trading. Altcoins led declines, with Binance Coin ove...